Redmile Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Redmile Group’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,380,327	Closed	-$38.5M	–	66
2024 Q3	$38.5M	Hold	16,380,327	–	–	2.27%	20
2024 Q2	$14.4M	Hold	16,380,327	–	–	0.87%	34
2024 Q1	$67M	Hold	16,380,327	–	–	2.46%	11
2023 Q4	$95.8M	Buy	16,380,327 +750,000	+5%	+$3.95M	3.43%	6
2023 Q3	$80.5M	Hold	15,630,327	–	–	3.83%	5
2023 Q2	$75.2M	Buy	15,630,327 +1,250,000	+9%	+$4.32M	2.89%	6
2023 Q1	$25M	Hold	14,380,327	–	–	1.09%	34
2022 Q4	$22.4M	Hold	14,380,327	–	–	0.92%	33
2022 Q3	$20.9M	Hold	14,380,327	–	–	0.81%	39
2022 Q2	$25.9M	Hold	14,380,327	–	–	0.99%	29
2022 Q1	$42.3M	Hold	14,380,327	–	–	1.32%	22
2021 Q4	$45.3M	Buy	+14,380,327	New	+$52.1M	1.03%	30

Redmile Group's AUGX Position: Q4 2024 in Review

Redmile Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 16,380,327 shares — an estimated $38.5M sold.

Redmile Group first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $95.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Redmile Group reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Redmile Group sold 16,380,327 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $38.5M.
Redmile Group first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
Redmile Group's Augmedix, Inc. Common Stock position peaked at $95.8M in Q4 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Redmile Group's 13F filing for Q4 2024, filed 14 Feb 2025.